Beijing Saiseng Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions. The Company
300485SZSE
Notice of Disclosure of 2025 Annual Report
✨ AI Summary
This announcement informs investors about the disclosure of Beijing Saiseng Pharmaceutical Co., Ltd.'s 2025 Annual Report and its summary. The report was approved by the board on March 29, 2026, and is available on the designated information disclosure website. Investors are encouraged to review the report to understand the company's operational performance, financial status, and future development plans.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.